Shop All
VIVI Cap
Insulin Pen Protection
VIVI Epi
EpiPen® Temperature Shield
Science
For Business
About
Loyalty Program
Investors
Support
Shop
News
Press release
Sidebar
Recent Posts
TempraMed Launches New Product, VIVI Cap Smart, Expanding its Portfolio to Include a Digital Health Offering
December 26, 2025
TempraMed Expands U.S. Manufacturing Capacity with New Production Facility in Florida
December 17, 2025
TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent
December 15, 2025
TempraMed Launches New Product, VIVI Cap Smart, Expanding its Portfolio to Include a Digital Health Offering
Dec 26, 2025
Download document ⤓
Read more
TempraMed Expands U.S. Manufacturing Capacity with New Production Facility in Florida
Dec 17, 2025
Download document ⤓
Read more
TempraMed Strengthens Global Intellectual Property Position with Grant of South Korean Patent
Dec 15, 2025
Download document ⤓
Read more
TempraMed Appoints Leading Diabetes Researcher Professor Dr. Lutz Heinemann to its Scientific Advisory Board
Dec 10, 2025
Download document ⤓
Read more
TempraMed Announces Strategic Agreement with Maccabi Healthcare Services, a Leading HMO with over 2.8 Million Patients
Dec 08, 2025
Download document ⤓
Read more
TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxembourg
Dec 05, 2025
Download document ⤓
Read more
TempraMed Signs Exclusive Commercial Distribution Agreement with Leading Distributor to the Turkish Market
Dec 02, 2025
Download document ⤓
Read more
TempraMed Signs Exclusive Distribution Agreement with Leading Consumer Health Distributor in Israel
Nov 26, 2025
Download document ⤓
Read more
Prev
1
2
Next
You have successfully subscribed!
This email has been registered